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René J.M. Bindels    Joost G.J. Hoenderop  
 Department of Physiology, Radboud University Nijmegen Medical Centre,  Nijmegen , The Netherlands
 
Homozygous TRPM6 deletion is embryonic lethal in mice. 
Heterozygous deletion of TRPM6 results in a mild hypomag-
nesemia. The Mg 2+ -enriched diet could not compensate for 
either embryonic lethality or hypomagnesemia caused by 
TRPM6 deficiency.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Magnesium (Mg 2+ ), the second most abundant elec-
trolyte in the body, participates in various physiological 
processes like muscle function and enzyme reactions  [1] . 
Mg 2+ homeostasis is maintained by the kidney (excre-
tion), intestine (absorption) and bone (storage)  [2, 3] . In 
the intestine, Mg 2+ uptake occurs via 2 distinct pathways, 
the active transcellular route and the passive paracellular 
way. The saturable transcellular route requires the entry 
of Mg 2+ into epithelial cells by specific ion channels at the 
luminal site and extrusion at the basolateral membrane 
via yet unidentified exchangers. Under physiological 
conditions, paracellular absorption is the major route  [3] . 
Following intestinal absorption, the kidney regulates the 
body’s Mg 2+ balance. In the glomeruli, about 80% of Mg 2+ 
is filtered, which is mainly reabsorbed passively in the 
proximal tubule and thick ascending limb of Henle’s 
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 Abstract 
 Background: Hypomagnesemia with secondary hypocalce-
mia is due to disturbed renal and intestinal magnesium 
(Mg 2+ ) (re)absorption. The underlying defect is a mutation in 
the transient receptor potential melastatin type 6 (TRPM6), a 
Mg 2+ -permeable ion channel expressed in the kidney and 
intestine. Our aim was to characterize homozygous (–/–) and 
heterozygous (+/–) TRPM6 knockout mice with respect to 
Mg 2+ homeostasis.  Methods: TRPM6 +/– mice were bred on a 
normal (0.19% wt/wt Mg 2+ ) and high (0.48% wt/wt Mg 2+ ) 
Mg 2+ diet. In the offspring, 24-hour urinary Mg 2+ and calcium 
excretion as well as serum concentrations of both were de-
termined. TRPM6 mRNA expression in the kidney and colon 
was measured.  Results: On the regular diet, 30% of the off-
spring were TRPM6 wild-type ( +/+ ), 70% were TRPM6 +/– , and 
none were TRPM6 –/– . The genotypic distribution of the litters 
remained the same on the 0.48% Mg 2+ diet. In TRPM6 +/– mice 
on both diets, serum Mg 2+ levels were significantly lower, 
and renal and intestinal TRPM6 mRNA expression was re-
duced. Urinary Mg 2+ excretion was unaffected.  Conclusions: 
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loop. The minority of filtered Mg 2+ (5–10%) is reabsorbed 
in the distal convoluted tubule (DCT) in an active, tran-
scellular manner  [4] . Mg 2+ reabsorption in the DCT de-
termines the final urinary excretion, because no reab-
sorption occurs beyond this nephron segment  [2] .
 Various disorders are related to disturbances in Mg 2+ 
homeostasis. Hypomagnesemia with secondary hypo-
calcemia (HSH; OMIM 602014) is a rare, hereditary dis-
order caused by disturbed renal and intestinal Mg 2+ (re)
absorption  [5–8] . The disease clinically manifests during 
the first months after birth, and symptoms comprise 
generalized seizures. HSH is characterized by low-serum 
Mg 2+ concentrations, and hypomagnesemia results in 
secondary hypocalcemia in patients  [9] . Therapy in-
cludes lifelong oral Mg 2+ administration to relieve clini-
cal symptoms and to normalize calcium (Ca 2+ ) homeo-
stasis, while serum Mg 2+ levels usually remain in the 
subnormal range (0.5–0.6 mmol/l, reference 0.7–1.1)  [10] . 
Numerous patients suffer from diarrhea, a side effect of 
oral Mg 2+ supplementation  [11] . Genetic screening of 
HSH patients identified mutations in transient receptor 
potential melastatin type 6 (TRPM6) as underlying de-
fect  [8, 12] . TRPM6 belongs to the TRPM subfamily of 
ion channels. TRPM6 has been characterized as an Mg 2+ -
permeable ion channel  [13] , which contains an   -kinase 
domain at the carboxy (C) terminus  [14, 15] . TRPM6 mu-
tations in HSH patients include point and missense mu-
tations, premature stops, inserted splice sites, frame 
shifts and exon deletions  [8, 11, 12, 16–18] . The muta-
tions are spread over the entire TRPM6 gene, and most 
result in truncation of the TRPM6 protein. Recently, 
Chubanov et al.  [16, 17] described 2 dominant negative 
TRPM6 missense mutations in HSH patients, S141L and 
P1017R, which directly affect the trafficking and func-
tion of this TRP channel.
 In humans, TRPM6 is abundantly expressed in the co-
lon and kidney (DCT); both sites are associated with ac-
tive Mg 2+ (re)absorption  [12] . The expression pattern of 
TRPM6 in mice resembles that of humans, although 
TRPM6 is also highly present in the lung  [19] . Colocaliza-
tion with the sodium-chloride cotransporter confirmed 
TRPM6 presence within the luminal membrane of DCT 
cells  [13] . Dietary Mg 2+ restriction was shown to increase 
TRPM6 mRNA and protein expression in the mouse kid-
ney  [19, 20] , while Mg 2+ supplementation induces TRPM6 
expression in the colon  [19, 20] . TRPM6 expression and 
Mg 2+ (re)absorption are also regulated by a variety of hor-
mones and compounds. Epidermal growth factor (EGF) 
and estrogen were discovered as magnesiotropic hor-
mones directly affecting TRPM6 expression  [19, 21] . EGF 
enhances activation of TRPM6 via the EGF receptor and 
intracellular signaling cascades  [22] . Recently, Glaude-
mans et al.  [23] discovered a missense mutation (N255D) 
in the voltage-gated potassium channel Kv1.1 in a Brazil-
ian family with isolated autosomal dominant hypomag-
nesemia. This Kv1.1 mutant depolarizes the membrane of 
the DCT, which reduces the driving force for Mg 2+ up-
take, resulting in renal Mg 2+ wasting in these patients 
 [23] .
 Another TRPM family member, TRPM7, is the second 
Mg 2+ permeable ion channel known. TRPM7 is the clos-
est homologue of TRPM6, but in contrast to TRPM6, the 
channel is ubiquitously expressed  [15, 24] . Similar to 
TRPM6, TRPM7 contains an   -kinase domain at the C 
terminus  [15, 24, 25] . In vitro and in vivo studies estab-
lished a role for TRPM7 in cell survival  [25, 26] . Jin et al. 
 [27] described that homozygous deletion of TRPM7 in 
mice results in embryonic lethality. Recently, Walder et 
al.  [28] showed that TRPM6 knockout mice suffer from 
embryonic lethality and neural tube defects. Their study 
mainly focused on the role of TRPM6 in embryogenesis 
and less on the role of TRPM6 and/or TRPM7 in Mg 2+ 
homeostasis. Therefore, the aim of our study was to gen-
erate and characterize TRPM6 +/– and TRPM6 –/– mice in 
order to examine the role of TRPM6 and TRPM7 in renal 
and intestinal Mg 2+ handling in more detail.
 Methods 
 Animal Studies 
 Male and female TRPM6 +/– mice were purchased from The 
Jackson Laboratory (JAX  Mice and Services, Bar Harbor, Me., 
USA; MGI: 2675603). These mice were bred to C57Bl/6J wild-type 
mice. The heterozygous offspring was bred to generate TRPM6 –/–
 mice. TRPM6 littermates were housed in a temperature- and 
light-controlled room with standard pellet chow (0.19% wt/wt 
Mg 2+ ; SSNIFF Spezialitäten GmbH, Soest, Germany) or a Mg 2+ -
enriched diet (0.48% wt/wt Mg 2+ ; SSNIFF) and deionized drink-
ing water available ad libitum. TRPM6 mice on the normal and 
high Mg 2+ diet (n = 10 per group) were housed in metabolic cages, 
and 24-hour urine and feces were collected. Blood samples were 
taken, and blood was led to clot at room temperature, incubated 
overnight at 4  °  C and spun down for 5 min at 13,250  g; the serum 
was used for analytical procedures. The animals were sacrificed, 
and kidney and colon tissues were sampled and frozen immedi-
ately in liquid nitrogen. Fresh urine was used for pH determina-
tion. Feces was dried for 8 h at 110  °  C, incinerated for 5 h at 625  °  C 
and resuspended in 2  M HCl overnight. The next day, the fecal 
solution was spun down for 15 min at 13,250  g, and the superna-
tant was used for the analytical procedures. All experiments were 
performed in compliance with the animal ethics board of the 
Radboud University Nijmegen.
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 Genotyping 
 Genotypes were determined by PCR with primers A (5  -
TGATTCAGATGCACTCCAGG-3  ) and B (5  -CATTCCCTG-
ATAAGGAAGGC-3  ) to detect the wild-type allele, and C (5  -
GCAGCGCATCGCCTTCTATC-3  ) and B (5  -CATTCCCTGAT-
AAGGAAGGC-3  ) to detect the null allele ( fig. 1 a, adapted from 
JAX  Mice and Services). The presence or absence of a 205-bp 
fragment (wild-type allele) or a 292-bp fragment (mutant allele) 
identifies animals with +/+, –/– and +/– genotypes ( fig. 1 b).
 Quantitative Real-Time PCR Analysis 
 Total RNA was isolated from the kidney and colon using 
TriZol Total RNA Isolation Reagent (Gibco BRL, Breda, The 
Netherlands) as described previously  [19] . cDNA was subsequent-
ly used to determine TRPM6 and TRPM7 mRNA expression lev-
els. mRNA expression of the housekeeping gene hypoxanthine-
guanine phosphorybosyl transferase was used as endogenous 
control. mRNA levels were quantified by qPCR on an ABI PRISM 
7900 HT Sequence Detection System (Applied Biosystems, Nieu-
werkerk a/d IJssel, The Netherlands). Primers and fluorescent 
probes were purchased from Biolegio (Malden, The Netherlands), 
and the sequences are listed elsewhere  [19] .
 Immunohistochemistry 
 Immunohistochemical staining of kidney sections with guin-
ea pig anti-TRPM6 and semiquantitative determination of the 
protein levels were performed as described previously  [19] .
 Analytical Procedures 
 Serum Mg 2+ and urinary and fecal Mg 2+ excretions were de-
termined using a colorimetric assay kit according to the manu-
facturer’s protocol (Roche Diagnostics, Woerden, The Nether-
lands). Serum, urine and feces Ca 2+ were measured as described 
previously  [29] .
 Statistical Analysis 
 Data are expressed as the mean  8 SEM. Statistical compari-
sons were analyzed by one-way ANOVA with a Bonferroni cor-
rection; p  ! 0.05 was considered statistically significant. All anal-
yses were performed using the Statview Statistical Package soft-
ware (Power PC version 4.51) on an Apple iMac computer.
 Results 
 Homozygous Deletion of TRPM6 Is Embryonic Lethal 
 Breeding TRPM6 +/– mice on a regular diet did not 
generate any TRPM6 –/– offspring. Of 119 littermates that 
were born, 36 mice (30%) were genotyped as TRPM6 +/+ , 
83 (70%) were genotyped TRPM6 +/– mice, and 0 (0%) 
were genotyped as TRPM6 –/– ( table 1 ). The average litter 
size was 6 (range 4–11). Since oral administration of Mg 2+ 
significantly improves the clinical symptoms of HSH pa-
tients  [10] , a similar approach was used to generate 
TRPM6 –/– mice. TRPM6 +/– breeding pairs were fed a 
high Mg 2+ diet, containing 2.5 times more Mg 2+ than the 
regular diet. The content of all other elements was identi-
cal in both diets. The offspring was fed this diet after 
weaning until the end of the experiments. In total, 113 
littermates were born ( table 1 ), of which 29 (26%) were 
genotyped TRPM6 +/+ mice, 84 (74%) TRPM6 +/– and 0 
(0%) TRPM6 –/– mice. We characterized the mice with a 
heterozygous deletion of TRPM6 and compared them 
with their wild-type littermates.
2 3
2 3
4
5 external probe
pKOS-35 (target vector)
A
B
C
LacZ/Neo
BamHIa EcoRI
3 external probe
BamHI EcoRI EcoRIBamHI
1 kb 20 25
bp
300 –
200 –
300 –
200 –
+/– +/+
b
 Fig. 1. Creation of null mutant mice for the TRPM6 gene locus.
 a Targeted inactivation of the TRPM6 gene. Top: wild-type allele. 
Bottom: targeted allele in which exons 2 and 3 are deleted. Grey 
boxes indicate exons; genotype primers (A–C) are depicted. LacZ/
Neo = Neomycin resistance cassette.  b Identification of the mouse 
genotype by PCR analysis of ear-derived DNA. The PCR product 
in the upper gel shows the presence of the wild-type allele (+/+) 
using primers A and B; the lower gel shows the knockout allele 
(–/–) using primers B and C. Both alleles are detected in hetero-
zygous animals (+/–). 
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 Mg 2+ and Ca 2+ Composition of Urine and Feces
Is Not Altered in TRPM6 +/– Mice 
 Mice between 8 and10 weeks of age were housed in 
metabolic cages for 24 h, and urine and feces were col-
lected to study Mg 2+ and Ca 2+ metabolism. The body-
weight of the TRPM6 +/– mice on a regular or high Mg 2+ 
diet was similar to their wild-type littermates ( table 2 ). 
Water intake, urine output and feces production in 24 h 
were comparable for all groups studied ( table  2 ). Total 
urinary Mg 2+ and Ca 2+ excretion is shown in  figure 2 . 
TRPM6 +/– and TRPM6 +/+ mice on control diet excreted 
the same amount of both electrolytes in 24 h ( fig. 2 a, b). 
Mice fed the high Mg 2+ diet excreted significantly more 
Mg 2+ and Ca 2+ in their urine compared with mice on the 
control diet ( fig. 2 a, b), but no significant differences be-
tween the 2 genotypes were observed. Urinary pH was 
not significantly affected by either heterozygous deletion 
of TRPM6 or by the high Mg 2+ diet ( fig. 2 c). Total fecal 
Mg 2+ and Ca 2+ excretion in 24 h was not significantly dif-
ferent between TRPM6 +/– and TRPM6 +/+ mice (data not 
shown).
 Heterozygous TRPM6 Deletion Causes a Mild 
Hypomagnesemia 
 On a regular diet, TRPM6 +/– mice displayed a slight, 
but significantly lower serum Mg 2+ concentration com-
pared with wild-type littermates ( fig.  3 a). Serum Mg 2+ 
levels in TRPM6 +/+ mice on a regular diet was 0.89  8 0.01 
versus 0.86  8 0.01 m M for TRPM6 +/– mice. Serum Ca 2+ 
concentrations were not altered in the TRPM6 +/– mice 
Table 1. L itter characteristics of TRPM6+/– breeding pairs on a 
regular or high Mg2+ diet
Regular diet High Mg2+ diet
Total offspring 119 (100) 113 (100)
Wild-type 36 (30) 29 (26)
Heterozygote 83 (70) 84 (74)
Homozygote 0 0
Litter size
Mean 6.1 5.4
Range 4–11 2–9
T otal offspring born from TRPM6+/– breeding pairs on a regu-
lar (0.19% wt/wt Mg2+) or high Mg2+ diet (0.48% wt/wt Mg2+) ar-
ranged based on genotype. Data are expressed as absolute num-
bers and percentages (in parentheses) of total offspring born.
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 Fig. 2. Effect of heterozygous deletion of TRPM6 on total urinary 
Mg 2+ and Ca 2+ excretion, and urinary pH. Net urinary excretion 
of Mg 2+ ( a ) and Ca 2+ ( b ) and urinary pH ( c ) in wild-type (+/+) or 
heterozygote (+/–) TRPM6 mice fed a regular diet (0.19% wt/wt 
Mg 2+ ) or a high Mg 2+ diet (0.48% wt/wt Mg 2+ ). Data are presented 
as the means  8 SEM (n = 10 per group).  a  p  ! 0.05 versus TRPM6 +/+ 
on a 0.19% Mg 2+ diet;  b  p  ! 0.05 versus TRPM6 +/– on a 0.19% Mg 2+ 
diet. 
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compared with wild-type littermates ( fig. 3 b). TRPM6 +/–
 mice fed a Mg 2+ -enriched diet also showed significantly 
lower serum Mg 2+ levels (0.83  8 0.02 vs. 0.89  8 0.01 m M 
for TRPM6 +/+ mice;  fig. 3 a), whereas serum Ca 2+ concen-
trations were similar for both genotypes ( fig. 3 b). The se-
rum Ca 2+ levels in TRPM6 +/– mice on the Mg 2+ -enriched 
diet are significantly reduced compared with those of 
mice on a control diet ( fig. 3 b).
 TRPM6 Gene Expression Is Reduced in TRPM6 +/– 
Mice 
 First, real-time PCR analysis was used to confirm the 
high TRPM6 mRNA expression in the kidney and colon 
of TRPM6 +/+ mice ( fig.  4 a, d)  [19] . In the kidney of 
TRPM6 +/– mice, TRPM6 mRNA levels were significant-
ly lowered by 50 and 53%, respectively, compared with 
TRPM6 +/+ mice on the control or Mg 2+ -enriched diet 
( fig. 4 a). Renal TRPM6 protein expression was not sig-
nificantly reduced in TRPM6 +/– mice on either diet 
( fig. 4 b, c). TRPM6 gene expression in the colon was also 
significantly reduced by 54% in mice fed the high Mg 2+ 
diet ( fig. 4 d). On the regular diet, TRPM6 mRNA levels 
in the colon of TRPM6 +/– mice were lowered by 33% rel-
ative to TRPM6 +/+ mice, an effect almost reaching sig-
nificance (p = 0.0503;  fig. 4 d). TRPM7 gene expression 
in the kidney and colon was comparable for the 2 geno-
types on the control and high Mg 2+ diet ( fig. 4 e, f). The 
Mg 2+ -enriched diet did not significantly change renal or 
intestinal TRPM6 or TRPM7 mRNA or protein levels 
( fig. 4 ).
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 Fig. 3. Effect of heterozygous deletion of TRPM6 on serum Mg 2+ 
and Ca 2+ concentrations. Serum Mg 2+ ( a ) and Ca 2+ ( b ) levels in 
wild-type (+/+) or heterozygote (+/–) TRPM6 mice on a regular 
diet (0.19% wt/wt Mg 2+ ) or a Mg 2+ -enriched diet (0.48% wt/wt 
Mg 2+ ). Data are presented as the means  8 SEM (n = 10 per group). 
 a  p  ! 0.05 versus TRPM6 +/+ on a 0.19% Mg 2+ diet;  b  p  ! 0.05 versus 
TRPM6 +/– on a 0.19% Mg 2+ diet;   c  p  ! 0.05 versus TRPM6 +/+ on a 
0.48% Mg 2+ diet. 
Parameter 0.19% Mg2+ 0 .48% Mg2+
TRPM6+/+ TRPM6+/– TRPM6+/+ TRPM6+/–
Weight, g 26.181.8 26.481.7 24.981.3 23.881.1
H2O intake, ml/day 5.280.4 5.680.3 4.780.5 4.980.7
Feces, g/day 1.280.1 1.080.1 0.780.1* 0.780.1
Urine volume, ml/day 0.880.2 0.780.1 0.780.2 0.680.1
TRP M6+/– and TRPM6+/+ mice on a regular (0.19% wt/wt Mg2+) or high (0.48% wt/
wt Mg2+) Mg2+ diet (n = 10 per group) were housed in metabolic cages for 24 h. Body-
weight at the start of the experiment, water intake, excreted feces and urine per 24 h were 
measured. Results are displayed as the average 8 SEM. * p < 0.05 versus TRPM6+/+ on a 
0.19% Mg2+ diet.
Table 2. P hysiological parameters from 
TRPM6+/+ and TRPM6+/– mice on a 
regular or high Mg2+ diet
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 Fig. 4. Effect of heterozygous deletion of TRPM6 on TRPM6 and 
TRPM7 gene and protein expression. TRPM6 ( a ,  d ) and TRPM7 
( e , f ) gene expression in the kidney ( a ,  e ) and colon ( d ,  f ), and re-
nal TRPM6 protein expression [representative images  ( b ); quan-
tification of protein expression ( c )] of wild-type (WT) (+/+) or 
heterozygote (+/–) TRPM6 mice on a regular diet (0.19% wt/wt 
Mg 2+ ) or a Mg 2+ -enriched diet (0.48% wt/wt Mg 2+ ). Data are pre-
sented as the means  8 SEM (n = 10 per group).  a  p  ! 0.05 versus 
TRPM +/+ on 0.19% Mg 2+ diet;  c   p  ! 0.05 versus TRPM6 +/+ on 
0.48% Mg 2+ diet. HPRT = Hypoxanthine-guanine phosphorybo-
syl transferase. 
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 Discussion 
 Our study demonstrated that homozygous deletion of 
TRPM6 in mice leads to embryonic lethality, which could 
not be rescued by feeding the mice an a Mg 2+ -enriched 
diet. Furthermore, the heterozygous deletion of TRPM6 
resulted in a mild hypomagnesemia without hypocalce-
mia. The hypomagnesemia could not be prevented by the 
Mg 2+ -enriched diet. In TRPM6 +/– mice, TRPM6 gene ex-
pression in the kidney and colon was downregulated, 
which most likely caused the reduction in serum Mg 2+ 
levels. Our results stress the importance of TRPM6 in 
maintaining Mg 2+ homeostasis. 
 Breeding TRPM6 +/– mice did not produce offspring 
that carried the homozygous deletion of TRPM6. Our ob-
servation suggests that TRPM6 plays an essential role in 
embryogenesis, which is in line with a recent publication 
by Walder et al.  [28] and Jin et al.  [27] , describing embry-
onic lethality for the TRPM6 –/– and TRPM7 –/– mice, re-
spectively. In humans, TRPM6 mutations result in hypo-
magnesemia, but no lethality is associated with TRPM6 
dysfunction, even though most mutations result in trun-
cation of the protein  [8, 11, 12, 16–18] . This discrepancy 
could be related to different expression patterns in hu-
man and mouse, and TRPM6 expression in the human 
lung remains to be determined. Another possibility might 
be a consequence of the role of TRPM6 in embryogenesis 
in human or mouse. In mouse, TRPM6 is crucial during 
embryogenesis; its expression is peaking at day 10.5 after 
conception, and a complete lack of TRPM6 results in neu-
ral tube defects and lethality  [28] . TRPM6 apparently 
plays a less significant role in humans in embryogene-
sis, since no significant link between miscarriages and 
TRPM6 families has been reported. Our approach to pre-
vent the embryonic lethality is based on patient observa-
tions  [10] . Increasing the Mg 2+ intake enhanced the pas-
sive paracellular pathway of Mg 2+ (re)absorption, which 
significantly improves hypomagnesemia in patients with 
HSH  [10] . We reasoned that a similar approach might res-
cue the lethality of TRPM6 –/– mice. Therefore, TRPM6 +/–
 breeding pairs and their offspring were fed a Mg 2+ -en-
riched diet. Increased urinary Mg 2+ and Ca 2+ excretion 
demonstrated the functionality of the diet ( fig.  2 a, b) 
without affecting the serum Mg 2+ concentration ( fig.
3 a), confirming previous observations  [19] . The litters 
consist of TRPM6 +/+ and TRPM6 +/– mice only, hence no 
TRPM6 –/– mice survived embryogenesis, nor did we ob-
serve a high frequency of stillbirth or perinatal death. 
Thus, our theory was rejected, and the TRPM6 –/– mice 
could not be rescued with this approach. This is in con-
trast to the study by Walder et al.  [28] in which 4 out of 
105 offspring born from breedings on a high Mg 2+ diet 
were TRPM6 –/– . The total number of offspring is compa-
rable with our study (105 vs. 119); therefore, the birth of 
4–5 TRPM6 –/– mice could have been expected based on 
the distribution reported by Walder et al.  [28] . Since no 
TRPM6 –/– mice were obtained in our study, this suggests 
that TRPM6 –/– mice can survive sporadically. A differ-
ence in genetic background between the TRPM6 +/– mice 
used in the 2 studies might explain these variable obser-
vations, or it could be that the dietary Mg 2+ supplementa-
tion (0.48% w/w) in our study was below a certain thresh-
old and therefore could not rescue the TRPM6 –/– mice, 
since Walder et al.  [28] acquired 4 TRPM6 –/– mice on a 
diet containing 0.6% w/w Mg 2+ , which is slightly higher 
than in our experiments. Further investigations are re-
quired to understand this process. In our study, detailed 
analysis of embryonic lethality was not performed. There-
fore, further research is required to elucidate this mecha-
nism. It is interesting to speculate that the lethality is re-
lated to disturbances in Mg 2+ homeostasis, since hetero-
zygous deletion of TRPM6 leads to a mild hypomag-
nesemia in mice. Hypomagnesemia might become more 
severe and could be accompanied by hypocalcemia, sim-
ilar to HSH patients, if both TRPM6 alleles are inacti-
vated, although the results obtained with the TPRM7 –/– 
mice imply that other mechanisms than Mg 2+ homeosta-
sis are involved in premature death  [27] . However, the 
expression pattern of TRPM6 suggests a more specific 
role for this ion channel in Mg 2+ homeostasis than ubiq-
uitously expressed TRPM7  [12, 15, 24] . The suggestion 
made by Walder et al.  [28] , linking Mg 2+ to fetal malfor-
mations, might also explain the observed premature 
mortality. Another possible explanation for embryonic 
lethality might be related to the high expression of TRPM6 
in the lungs of mice  [19] , although a function of TRPM6 
in this tissue has not yet been described. In humans, 
TRPM6 expression in the lungs remains to be deter-
mined, nor has TRPM6 expression in the lung been 
linked to HSH so far. Generating conditional TRPM6 –/– 
mice in either a tissue- or developmental stage-specific 
manner would provide an animal model suitable for 
studying TRPM6 function in Mg 2+ handling. Time- or 
tissue-specific TRPM6 knockout mice, either in single or 
several tissues, can be generated using the well-known 
Cre-LoxP recombinase system first described by Gu et al. 
 [30] . Subsequently, cross-breeding of a kidney-specific 
TRPM6 –/– mouse with an intestine-specific TRPM6 –/– 
mouse will generate a mouse with targeted deletion of 
TRPM6 in both the kidney and colon. These conditional 
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knockout mice can be used to study the consequences of 
TRPM6 deletion in the kidney, colon or both on the whole 
organism and might help elucidating the role of TRPM6 
in the lung. 
 Hypomagnesemia most likely results from reduced 
TRPM6 mRNA expression in the kidney and colon in 
TRPM6 +/– mice, although a significant reduction in renal 
TRPM6 protein expression could not be observed in our 
study, which leads to a significant decrease in serum 
Mg 2+ levels, without a significant change in urinary Mg 2+ 
excretion. No differences in renal or intestinal TRPM7 
expression were observed in TRPM6 +/– mice, suggesting 
that the decrease in Mg 2+ (re)absorption is not compen-
sated for by TRPM7. The Mg 2+ -enriched diet increased 
the urinary Mg 2+ and Ca 2+ content, which is in line with 
a previous publication by Groenestege et al.  [19] . Serum 
Mg 2+ concentrations and TRPM6 expression in the kid-
ney and colon were not normalized by the high Mg 2+ diet 
in TRPM6 +/– mice. In TRPM6 +/+ mice, TRPM6 gene and 
protein and TRPM7 gene expression in the kidney and 
colon were not affected by the Mg 2+ -enriched diet. Our 
results are partially in line with a previous publication, 
reporting no changes in renal TRPM6 and TRPM7 ex-
pression, but significantly enhanced TRPM6 gene ex-
pression in the colon of C57Bl6 mice by a Mg 2+ -enriched 
diet  [19] . This discrepancy between the 2 studies might 
be explained by the timeframe of the experiment. In the 
previous report, the animals were fed the diet for a period 
of 10 days, starting at an age of 12 weeks  [19] , whereas in 
our study, mothers were fed the diet during breeding and 
weaning, and after weaning, the litters remained on the 
diet until the end of the experiments at an age of 8–10 
weeks. This implies that mice respond quickly to an
increased dietary Mg 2+ intake, by enhancing TRPM6 
mRNA expression in the colon, which stabilizes to con-
trol levels after a longer exposure to the diet.
 In conclusion, our data indicate that homozy-
gous TRPM6 deletion is embryonic lethal, as cross-
ing TRPM6 +/– breeding pairs did not generate any 
TRPM6 –/– mice. Feeding the breeding pairs a Mg 2+ -en-
riched diet could not compensate for the embryonic le-
thality caused by TRPM6 deficiency. Furthermore, our 
results clearly demonstrate the association of a mild phe-
notype with heterozygous deletion of TRPM6. TRPM6 +/–
 mice show a significant reduction in TRPM6 expression 
in the kidney and intestine, which is accompanied by a 
mild hypomagnesemia. Overall, our results emphasize 
the key role of TRPM6 in Mg 2+ homeostasis.
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